Companies: 10,795·Total market cap: $144.5T
CytoDyn Inc.

CytoDyn Inc.

CYDYOTCHealthcare● Active
$0.30
$-0.00(-1.21%)
Market Cap$404208392
P/E Ratio—
52W High$0.4
52W Low$0.21
SEC Filings

CytoDyn Inc. (CYDY) SEC Filings & 10-K Annual Reports

SEC EDGAR regulatory submissions (10-K, 10-Q, 8-K), latest forms, and full filing history — quick links to financials and earnings below.

SEC EDGAR · data.sec.gov · CIK 0001175680 · CYDY · OTC · as of Jun 10, 2026

Filing snapshot

1,005+
Total Filings
EFFECT
Latest Form
2026-05-20
Most Recent
2006
Filing Since
FinancialsEarningsView All on EDGAR

Source: SEC EDGAR (data.sec.gov) · CIK 0001175680 · Updated hourly · Not investment advice

Latest Annual Report

10-K · Annual ReportFY
Filed Date
2025-07-25
Fiscal Year End
Jul 25, 2025
Accession No.
0001558370-25-009617
Primary Document
cydy-20250531x10k.htm
View on SEC EDGARDownload PDFFiling Index
Source: data.sec.gov · CIK 0001175680 · Accession 0001558370-25-009617

Latest Key Filings

10-QQuarterly Report
10-Q
2026-04-08
View 10-Q on SEC
8-KCurrent Report
8-K
2026-04-30Material Event
View 8-K on SEC
Form 4Insider Activity
Ownership Change Disclosures

Executive & director trade disclosures. Full buy/sell sentiment analysis on the dedicated tab.

View Insider Trades Tab

SEC Filing History

Hide Form 4 / 144
EFFECTEFFECT
EFFECT
2026-05-20
View
424B3424B3
424B3
2026-05-20
View
DD
D
2026-05-11
View
8-KCurrent Report
8-K
2026-04-30
View
S-1IPO Registration Statement
S-1
2026-04-22
View
424B3424B3
424B3
2026-04-08
View
10-QQuarterly Report
10-Q
2026-04-08
View
424B3424B3
424B3
2026-03-25
View
8-KCurrent Report
8-K
2026-03-24
View
424B3424B3
424B3
2026-03-09
View
8-KCurrent Report
8-K
2026-03-05
View
424B3424B3
424B3
2026-01-09
View
10-QQuarterly Report
10-Q
2026-01-09
View
424B3424B3
424B3
2025-12-22
View
EFFECTEFFECT
EFFECT
2025-12-16
View
Showing 1–15 of 738 filingsForm 4 / 144 hidden· 1005 total in EDGAR

About SEC Filings & 10-K Annual Reports

Data source: SEC EDGAR (data.sec.gov)  |  Updated: Hourly  |  CIK: 0001175680  |  Exchange: OTC · Healthcare

CytoDyn Inc. (OTC: CYDY) has submitted 1,005+ documents to the U.S. Securities and Exchange Commission (SEC) since its IPO in 2006. As a Healthcare sector company with CIK 0001175680, all filings are publicly accessible via the EDGAR database at no cost.

The annual 10-K report is CytoDyn Inc.'s most comprehensive regulatory disclosure. The most recent CytoDyn Inc. 10-K was filed on 2025-07-25 for fiscal year ending 2025. Historical CYDY 10-K annual reports are available from 2015 through 2025.

Investors researching CytoDyn Inc. SEC filings can access 10-K annual reports, quarterly 10-Q reports, material event 8-K filings, and proxy statements directly from the links above. All documents are sourced from the official SEC EDGAR system.

Source: SEC EDGAR · data.sec.gov · SEC Form 10-K · SEC Form 10-Q · SEC Form 8-K2026-06-10
Related Companies SEC Filings — Healthcare
BOVNF SEC Filings →CLVLY SEC Filings →NWBO SEC Filings →CLVLF SEC Filings →FGHQF SEC Filings →HLOSF SEC Filings →CMVLF SEC Filings →HNSBF SEC Filings →
→ CYDY Financials→ CYDY Earnings→ CYDY Insider Trades

Frequently Asked Questions

CYDY SEC Filings · 8 questions

CytoDyn Inc. (CYDY) SEC filings are publicly available on this page and on the official SEC EDGAR database at sec.gov. You can browse all 1,005+ filings and access original documents at no cost. CytoDyn Inc.'s CIK is 0001175680.

CYDY SEC filingsCytoDyn Inc. SEC documentsfind CYDY 10-K